期刊文献+

肺癌患者同步放化疗期间症状群的调查研究 被引量:26

Analysis on Symptom Clusters in Patients with Lung Cancer Undergoing Concurrent Chemoradiation Therapy
下载PDF
导出
摘要 目的调查分析肺癌患者同步放化疗期间症状群的发生及分布特征。方法采用M.D安德森症状评估量表中文版(MDASI-C)对141例同步放化疗的肺癌患者进行调查。Spearman相关分析用于症状间相关性的分析;主成分分析用于提取患者的症状群。结果同步放化疗的肺癌患者疲乏症状强度得分最高,为(6.1±2.0)分,疲乏症状发生频率亦最高,为95.7%;MDASI-C各症状间均存在正相关(P<0.01),相关系数为0.13~0.74;主成分分析显示存在3个症状群:消化道症状群、情感症状群和病感症状群,3个症状群的内部信度Cronbach'sα系数分别为0.84、0.80和0.82。结论肺癌患者同步放化疗期间存在不同的症状群,认识该症状群有助于医护人员准确预见并为建立干预措施提供参考,以减轻肺癌患者的症状负担,提高其生活质量。 Objective To analyze the prevalence and distribution of symptom clusters in patient with lung cancer undergoing concurrent chemoradiation therapy(CCRT).Methods A total of 141 lung cancer patients undergoing CCRT were surveyed with a self designed demographic questionnaire and the Chinese version of the M.D Anderson symptom inventory(MDASI-C).Spearman correlation was used to analyze the correlation of the symptoms and principal component analysis(PCA) was used to extract symptom clusters.Results Lung cancer patients undergoing CCRT had the highest score for the intensity of fatigue symptoms(6.1±2.0),as well as the highest frequency of fatigue symptoms(95.7%).MDASI-C showed that the symptoms were positively correlated with each other(P0.01) with correlation coefficient being 0.13~0.74.PCA identified three symptom clusters,which were digestive tract symptom clusters,emotion symptom clusters and sickness feeling symptom clusters,and the Cronbach′s alpha coefficients for the three symptom clusters were 0.84,0.80 and 0.82.Conclusion There are three symptom clusters in patients with lung cancer during CCRT.Recognition of these symptom clusters is useful for medical staff to assess and provide effective interventions,which are conducive to symptom control and prevention and the improvement of life quality.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第33期3866-3869,共4页 Chinese General Practice
关键词 肺肿瘤 同步放化疗 症状群 M D安德森症状评估量表中文版 Lung neoplasms Concurrent chemoradiation therapy Symptom clusters The Chinese version of the M.D Anderson symptom inventory
  • 相关文献

参考文献25

  • 1Dodd M J, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer [ J ]. Oncol Nurs Forum, 2001, 28 (3): 465-470.
  • 2Chen ML, Tseng HC. Symptom clusters in cancer patients [ J]. Supportive Care in Cancer, 2006, 14 (8) : 825 -830.
  • 3Gift AG, Jablonski A, Stommel M, et al. Symptom clusters in elderly patients with lung cancer [J]. Oncol Nurs Forum, 2004, 31 (2) : 202 - 212.
  • 4Cooley ME. Symptoms in adults with lung cancer: A systematic research review [J]. Journal of Pain and Symptom Management, 2000, 19 (2): 137-153.
  • 5李焱,杨敬敬.沙利度胺与NP方案联合治疗晚期非小细胞肺癌的疗效观察[J].疑难病杂志,2011,10(6):435-437. 被引量:14
  • 6Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, andguidelines [J]. J Clin Oncol, 1984, 2 (3): 187-193.
  • 7Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients the M. D. Anderson Symptom Inventory [ J ]. Cancer, 2000, 89 (7) : 1634 -1646.
  • 8Wang XS, Wang Y, Guo H, et al. Chinese version of the MD Anderson Symptom Inventory ( MDASI - C) : Validation and application of symptom measurement in cancer patients [J]. Cancer, 2004, 101 (8) : 1890 - 1901.
  • 9闫玲,姜永亲,王瑛.对249例癌症患者症状的调查[J].中华护理杂志,2005,40(4):283-285. 被引量:46
  • 10Tong H, Isenring E, Yates P. The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients [J]. Supportive Care in Cancer, 2009, 17 (1): 83-90.

二级参考文献51

  • 1王瑞林,宋文广,付占昭,张志勇,吴瑜,钟延丰,王胜兰.脑转移癌血脑屏障变化的免疫组化及超微结构研究[J].中国肿瘤临床,2004,31(17):977-979. 被引量:23
  • 2廖小方,郑勤红,何慧娟,胡伟.每日低剂量顺铂同步放疗非小细胞肺癌临床研究[J].中华放射肿瘤学杂志,2006,15(3):232-233. 被引量:7
  • 3刘联,王秀问,黎莉,张昕,张文东,于学军.含顺铂的三组联合化疗方案治疗晚期非小细胞肺癌的随机对照临床研究[J].癌症,2006,25(8):990-994. 被引量:93
  • 4吴一龙,蒋国樑,陆舜,等.中国抗癌协会肺癌专业委员会.2008中国肺癌临床指南[M].北京:人民卫生出版社,2008:73-74.
  • 5Ohe Y,Ohashi Y,Kubota K,et al.Randomized phase Ⅲ study of cisplatin plus irinotecan versus carboplatin plus paclitaxel,cisplatin plus gemcitabine,and cisplatin plus vinorelbine for advanced non-small-cell lung cancel[J].Four-Arm Cooperative Study in Japan Ann Oncol,2007,18(2):317-323.
  • 6Zhang ZL,Liu ZS,Sun Q.Effects of thalidomide on angiogenesis and tumor growth and metastasis of human hepatocellular carcinoma in nude mice[J].World J Gastroenterol,2007,1l(2):216-220.
  • 7Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small cell lung cancer[J].N Engl J Med,2002,346(2):92-98.
  • 8Hada MM,Horiuchi T.A case report of chemotherapy with thalidomide,celecoxib and gemcitabine in the treatment of patients with brain metastases[J].J Clin Oncol,2008,33(10):1021-1026.
  • 9Gelati M,Corsini E,Frigerio S,et al.Effects of thalidomide on parameters involved in angiogenesis:an in vitro study[J].J Neurooncol,2003,64(3):193-201.
  • 10Fujita K,Asami Y,Tanaka K,et al.Anti-angiogenic effects of thalidomide:expression of apoptosis-inducible active-caspase-3 in a three-dimensional collagen gel culture of aorta[J].Histochem Cell Biol,2007,122(1):27-33.

共引文献97

同被引文献266

引证文献26

二级引证文献238

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部